These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 8301215

  • 21. Generation of leukotrienes from normal epidermis and their demonstration in cutaneous disease.
    Rosenbach T, Grabbe J, Möller A, Schwanitz HJ, Czarnetzki BM.
    Br J Dermatol; 1985 Jul; 113 Suppl 28():157-67. PubMed ID: 2990517
    [Abstract] [Full Text] [Related]

  • 22. Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils.
    Wardlaw AJ, Moqbel R, Cromwell O, Kay AB.
    J Clin Invest; 1986 Dec; 78(6):1701-6. PubMed ID: 3023451
    [Abstract] [Full Text] [Related]

  • 23. Theophylline attenuates the neutrophil-dependent augmentation of eosinophil trans-basement membrane migration.
    Kikuchi I, Kikuchi S, Kobayashi T, Takaku Y, Hagiwara K, Kanazawa M, Nagata M.
    Int Arch Allergy Immunol; 2007 Dec; 143 Suppl 1():44-9. PubMed ID: 17541276
    [Abstract] [Full Text] [Related]

  • 24. The effect of leukotriene B4, leukotriene C4, zymosan activated serum, histamine, tabanid extract and N-formyl-methionyl-leucyl-phenylalanine on the in vitro migration of equine eosinophils.
    McEwen BJ, Wilcock BP, Eyre P.
    Can J Vet Res; 1990 Oct; 54(4):400-4. PubMed ID: 2174292
    [Abstract] [Full Text] [Related]

  • 25. Effects of novel lipoxygenase products on migration of eosinophils and neutrophils in vitro.
    Udén AM, Palmblad J, Lindgren JA, Malmsten C.
    Int Arch Allergy Appl Immunol; 1983 Oct; 72(1):91-3. PubMed ID: 6307891
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Leukotriene D4 and eosinophil transendothelial migration, superoxide generation, and degranulation via beta2 integrin.
    Saito K, Nagata M, Kikuchi I, Sakamoto Y.
    Ann Allergy Asthma Immunol; 2004 Dec; 93(6):594-600. PubMed ID: 15609771
    [Abstract] [Full Text] [Related]

  • 28. Platelet activating factor is a mediator of equine neutrophil and eosinophil migration in vitro.
    Foster AP, Lees P, Cunningham FM.
    Res Vet Sci; 1992 Sep; 53(2):223-9. PubMed ID: 1332153
    [Abstract] [Full Text] [Related]

  • 29. Modulation of eosinophil chemotactic activities to leukotriene B4 by n-3 polyunsaturated fatty acids.
    Kikuchi S, Sakamoto T, Ishikawa C, Yazawa K, Torii S.
    Prostaglandins Leukot Essent Fatty Acids; 1998 Mar; 58(3):243-8. PubMed ID: 9610849
    [Abstract] [Full Text] [Related]

  • 30. Platelet-activating factor-induced human eosinophil transendothelial migration: evidence for a dynamic role of the endothelium.
    Casale TB, Erger RA, Little MM.
    Am J Respir Cell Mol Biol; 1993 Jan; 8(1):77-82. PubMed ID: 8380250
    [Abstract] [Full Text] [Related]

  • 31. Eosinophil chemotaxis inhibited by 5-lipoxygenase blockade and leukotriene receptor antagonism.
    Muñoz NM, Douglas I, Mayer D, Herrnreiter A, Zhu X, Leff AR.
    Am J Respir Crit Care Med; 1997 Apr; 155(4):1398-403. PubMed ID: 9105085
    [Abstract] [Full Text] [Related]

  • 32. The inhibitory effect of methotrexate on PAF-induced neutrophil and eosinophil locomotion in asthmatic patients.
    Tsai JJ, Wang TF, Wang SR.
    Asian Pac J Allergy Immunol; 1994 Jun; 12(1):65-71. PubMed ID: 7872994
    [Abstract] [Full Text] [Related]

  • 33. Comparative studies of human eosinophil migration towards platelet-activating factor and leukotriene B4.
    Czarnetzki BM, Csatò M.
    Int Arch Allergy Appl Immunol; 1989 Jun; 88(1-2):191-3. PubMed ID: 2540094
    [Abstract] [Full Text] [Related]

  • 34. Leukotriene B4 is a potent and stereospecific stimulator of neutrophil chemotaxis and adherence.
    Palmblad J, Malmsten CL, Udén AM, Rådmark O, Engstedt L, Samuelsson B.
    Blood; 1981 Sep; 58(3):658-61. PubMed ID: 6266432
    [Abstract] [Full Text] [Related]

  • 35. Lipoxin A4 and B4 inhibit leukotriene-stimulated interactions of human neutrophils and endothelial cells.
    Papayianni A, Serhan CN, Brady HR.
    J Immunol; 1996 Mar 15; 156(6):2264-72. PubMed ID: 8690917
    [Abstract] [Full Text] [Related]

  • 36. Differential effects of the PAF receptor antagonist UK-74,505 on neutrophil and eosinophil accumulation in guinea-pig skin.
    Sanz MJ, Weg VB, Walsh DT, Williams TJ, Nourshargh S.
    Br J Pharmacol; 1994 Oct 15; 113(2):513-21. PubMed ID: 7834203
    [Abstract] [Full Text] [Related]

  • 37. Neuropeptides modulate human eosinophil chemotaxis.
    Numao T, Agrawal DK.
    J Immunol; 1992 Nov 15; 149(10):3309-15. PubMed ID: 1385521
    [Abstract] [Full Text] [Related]

  • 38. Leukotriene receptors in HL-60 cells differentiated into eosinophils, monocytes and neutrophils.
    Patry C, Müller E, Laporte J, Rola-Pleszczynski M, Sirois P, de Brum-Fernandes AJ.
    Prostaglandins Leukot Essent Fatty Acids; 1996 May 15; 54(5):361-70. PubMed ID: 8832765
    [Abstract] [Full Text] [Related]

  • 39. Characteristics of the cellular response of the rat conjunctiva to topically applied leukotriene B4.
    Trocmé SD, Gilbert CM, Allansmith MR, Bloch KJ, Abelson MB.
    Ophthalmic Res; 1989 May 15; 21(4):297-302. PubMed ID: 2555760
    [Abstract] [Full Text] [Related]

  • 40. Leukotrienes cause eosinophil emigration into conjunctival tissue.
    Spada CS, Woodward DF, Hawley SB, Nieves AL.
    Prostaglandins; 1986 Apr 15; 31(4):795-809. PubMed ID: 3014611
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.